How Much Does Wegovy Cost Without Insurance in 2026? Dose-by-Dose Breakdown
Key Takeaways
- Wegovy's list price remains ~$1,349/month, but almost nobody pays that — real cash prices range from $149 to $399/month depending on format and dose
- The Wegovy pill (launched January 2026) starts at $149/month for lower doses, making it the cheapest brand-name Wegovy option
- Medicare beneficiaries pay $50/month flat through the GLP-1 Bridge Program (started July 1, 2026)
- With commercial insurance + savings card, eligible patients can pay as little as $25/month
- Compounded semaglutide alternatives start as low as $99/month — but are not FDA-approved
If you've looked up the price of Wegovy recently, you've probably seen a number around $1,349 per month. That's the list price — and it's also the number you can almost certainly ignore.
Between manufacturer self-pay programs, the new oral Wegovy pill, the TrumpRx pricing initiative, the Medicare GLP-1 Bridge, and compounded alternatives, what people actually pay for semaglutide-based weight loss treatment in 2026 varies enormously. This guide breaks down every Wegovy cost pathway, dose by dose, with verified pricing as of July 2026.
Wegovy Injection Pricing: Dose-by-Dose Breakdown
Wegovy injections come as a once-weekly pen in five dose strengths, plus the newer high-dose 7.2 mg "Wegovy HD" option. Here's what you'll actually pay without insurance through Novo Nordisk's NovoCare self-pay program:
| Dose | List Price | NovoCare Self-Pay | Subscription (3-mo) | Medicare Bridge |
|---|---|---|---|---|
| 0.25 mg (starter) | $1,349 | $199* | $329/mo | $50/mo |
| 0.5 mg | $1,349 | $199* | $329/mo | $50/mo |
| 1 mg | $1,349 | $349 | $329/mo | $50/mo |
| 1.7 mg | $1,349 | $349 | $329/mo | $50/mo |
| 2.4 mg (maintenance) | $1,349 | $349 | $329/mo | $50/mo |
| 7.2 mg HD | $1,349 | $399 | TBD | $50/mo |
*$199 intro price for new patients on 0.25 mg or 0.5 mg for the first 2 monthly fills through August 31, 2026, then $349/month. Subscription pricing requires pre-paying for 3, 6, or 12 months. Prices verified July 2026 via Novo Nordisk / NovoCare.
Novo Nordisk now offers "commitment pricing" through NovoCare and telehealth partners (Ro, WeightWatchers, LifeMD, Hims & Hers, Sesame). A 3-month subscription brings the pen price to $329/month — saving up to $240/year compared to month-to-month. Longer commitments unlock even deeper discounts through December 31, 2026.
Wegovy Pill Pricing: The January 2026 Game-Changer
The oral Wegovy pill launched in January 2026 and immediately became the cheapest way to access brand-name semaglutide for weight loss. It uses the same active ingredient as the injection but in a daily tablet form. Doses are different from the pen — here's the pricing breakdown:
| Pill Dose | List Price | NovoCare Self-Pay | With Savings Card + Insurance | Medicare Bridge |
|---|---|---|---|---|
| 1.5 mg (starter) | $1,350 | $149 | $25 | $50/mo |
| 4 mg | $1,350 | $149† | $25 | $50/mo |
| 9 mg | $1,350 | $299 | $25 | $50/mo |
| 25 mg (maintenance) | $1,350 | $299 | $25 | $50/mo |
†The $149 price for 4 mg tablets is a limited-time offer available until August 31, 2026 — after that date, the 4 mg dose rises to $199/month. One month = 30 tablets.
Oral Wegovy must be taken on an empty stomach with no more than 4 ounces of plain water, then you must wait at least 30 minutes before eating, drinking, or taking other medications. This is different from Foundayo (orforglipron), which has no food or water restrictions.
Insurance + Savings Card: The $25/Month Path
If you have commercial (employer or marketplace) insurance that covers Wegovy, the Novo Nordisk savings card can bring your copay down to as low as $25 per month for either the pen or the pill. The card provides up to $100 in savings per monthly fill, $200 per 2-month fill, or $300 per 3-month fill.
The catch: not all commercial plans cover Wegovy for weight loss. Some major insurers (including some Blue Cross Blue Shield plans in 2026) are excluding Wegovy from weight-loss coverage entirely. Plans that cover it for cardiovascular risk reduction may still authorize it if your doctor prescribes it for that indication.
Government beneficiaries — including Medicare and Medicaid enrollees — are excluded from the commercial savings card. Medicare patients should use the GLP-1 Bridge Program instead.
Medicare GLP-1 Bridge: $50/Month Starting July 1, 2026
The Medicare GLP-1 Bridge is a temporary federal program that launched July 1, 2026 and runs through December 31, 2027. It provides all dose strengths of Wegovy (both pen and pill) for a flat $50/month copay.
Eligibility requirements:
- Group 1: BMI ≥ 35 (no additional conditions required)
- Group 2: BMI 30–34.99 with at least one documented weight-related comorbidity
- Group 3: BMI 27–29.99 with documented prediabetes, history of stroke, history of heart attack, or symptomatic peripheral artery disease
You must be enrolled in an eligible Medicare Part D plan (standalone PDP or MA-PD). The $50 copay does not count toward your annual deductible or out-of-pocket maximum.
Your pharmacy submits the Wegovy claim to your standard Part D plan first. That claim is deliberately rejected with a structured code, which automatically triggers the central Bridge Program processor. It sounds complicated, but your pharmacy handles it — you just pay $50.
TrumpRx.gov: Federal Cash-Price Access
The TrumpRx.gov platform, launched in February 2026, uses Most-Favored-Nation international pricing agreements to offer steep cash discounts on brand-name GLP-1 medications — no insurance required.
| Medication | TrumpRx Price | Standard List Price | Savings |
|---|---|---|---|
| Wegovy Injection | ~$350/mo | $1,349 | ~74% |
| Wegovy Injection (lower strengths) | As low as $199 | $1,349 | ~85% |
| Wegovy Pill | As low as $149 | $1,350 | ~89% |
TrumpRx prices are approximate and may vary. Verified July 2026 via published reporting on TrumpRx.gov pricing agreements.
Compounded Semaglutide: The Budget Alternative
Compounded semaglutide from telehealth providers remains the least expensive pathway to semaglutide-based weight loss treatment. These formulations are prepared by state-licensed 503A pharmacies based on individual prescriptions.
Compounded medications are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA. Compounded semaglutide is not the same as Wegovy — it is a pharmacy-prepared formulation and should never be described as "generic Wegovy" or implied to carry FDA approval.
That said, compounded semaglutide is widely available through licensed telehealth providers, and prices have compressed significantly in 2026 due to competition. Here are verified starting prices from providers we track:
Injectable
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Check Current Pricing →Paid link · We may earn a commission
Injectable semaglutide
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Check Current Pricing →Paid link · We may earn a commission
Injectable only
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Check Current Pricing →Paid link · We may earn a commission
Injectable tirzepatide
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Check Current Pricing →Paid link · We may earn a commission
Side-by-Side: Every Wegovy Price Path in 2026
| Access Pathway | Monthly Cost | Who Qualifies |
|---|---|---|
| Medicare GLP-1 Bridge | $50 | Medicare Part D enrollees meeting BMI criteria |
| Commercial insurance + savings card | $25 | Commercial plans that cover Wegovy |
| Compounded semaglutide (lowest) | $99 | Anyone with a prescription (not FDA-approved) |
| Wegovy Pill via NovoCare (1.5/4 mg) | $149 | Anyone (self-pay, no insurance needed) |
| TrumpRx — injection (low dose) | ~$199 | Anyone (cash-price platform) |
| Wegovy Pill via NovoCare (9/25 mg) | $299 | Anyone (self-pay) |
| Wegovy Pen — subscription | $329 | 3-month pre-pay through telehealth partners |
| Wegovy Pen via NovoCare | $349 | Anyone (self-pay) |
| Wegovy HD 7.2 mg via NovoCare | $399 | Anyone (self-pay) |
| Retail pharmacy (no discounts) | $1,349 | Anyone — but you shouldn't pay this |
Which Price Path Is Right for You?
If you have Medicare: The GLP-1 Bridge at $50/month is the clear winner. Check your eligibility immediately — this program runs through December 2027 but enrollment volume may be limited.
If you have commercial insurance that covers Wegovy: Use the savings card and pay $25/month. If your plan doesn't cover Wegovy for weight loss, ask your doctor about the cardiovascular-risk-reduction indication — some plans cover it under that approval.
If you're uninsured and prefer brand-name: The Wegovy pill at $149/month (for lower doses) or TrumpRx at $199–$350/month are your best options. The pill is worth considering if you're comfortable with daily dosing and the fasting requirement.
If you want the lowest possible cost: Compounded semaglutide through telehealth providers starts at $99/month. Just understand the FDA-approval trade-off and verify that your provider uses a licensed, accredited compounding pharmacy.
Nobody should be paying $1,349/month for Wegovy in 2026. Between the oral pill launch, the Medicare Bridge, TrumpRx, manufacturer savings, and compounded alternatives, the real cost of semaglutide for weight loss now ranges from $50 to $399 per month — a fraction of the list price. Start with the pathway that matches your insurance status, then work your way down.
Prices verified as of July 15, 2026. Manufacturer programs, insurance coverage, and pricing may change. Always confirm current pricing with your pharmacy or provider before starting treatment. This article will be updated monthly.